24-Month Safety Outcomes in SAKURA Study 1: Treatment of Non-infectious Uveitis (NIU) of the Posterior Segment With Intravitreal Sirolimus

被引：0

作者：

Thurau, Stephan R. ^{[1
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Munich, Germany

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

1884

引用

页数：2

共 50 条

[1] Long-Term Safety of Intravitreal Sirolimus for the Treatment of Non-infectious Uveitis (NIU) of the Posterior Segment: 12-Month Results from SAKURA Study 1
Merrill, Pauline T.
Yang, Yang
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[2] 24-Month Safety Outcomes with Every-Other-Month Injections of Intravitreal Sirolimus, a Local mTOR Inhibitor, in Subjects with Active Non-Infectious Uveitis of the Posterior Segment Participating in the SAKURA Study 1
Quan Dong Nguyen
[J]. OPHTHALMOLOGICA, 2016, 236 : 35 - 35
[3] Long-Term Safety of Intravitreal Sirolimus for the Treatment of Non-infectious Uveitis (MU) of the Posterior Segment: 12-Month SAKURA Study 1 Results
Bodaghi, B.
Pavesio, C.
Alfredo, A. C.
Valentine, M. E.
[J]. ACTA OPHTHALMOLOGICA, 2015, 93
[4] Pharmacokinetics of Intravitreal Sirolimus in Non- infectious Uveitis (NIU) of the Posterior Segment: Results from a Subset of SAKURA Study 1 Subjects
Rosberger, Daniel
Yang, Yang
Kageyama, Masaaki
Mano, Hidetoshi
Takenaga, Hitomi
Ueda, Kenji
Lawrence-Miyasaki, Lisa
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[5] IMPROVED VISUAL FUNCTION IS ASOCIATED WITH INFLAMMATION REDUCTION IN SUBJECTS WITH NON-INFECTIOUS UVEITIS (NIU) OF THE POSTERIOR SEGMENT TREATED WITH INTRAVITREAL SIROLIMUS: RESULTSFROM SAKURA STUDY 1
Lescrauwaet, B.
Duchateau, L.
Verstraeten, T.
Thurau, S.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A426 - A426
[6] Visual Acuity Response to Every-Other-Month Intravitreal Sirolimus Injections in Subjects with Active Non-Infectious Uveitis of the Posterior Segment (NIU-PS) Participating in SAKURA Study 1
Grajewski, Rafael
[J]. OPHTHALMOLOGICA, 2016, 236 : 34 - 34
[7] Corticosteroid Tapering Success With Every-Other-Month Intravitreal Sirolimus for Non-infectious Uveitis of the Posterior Segment: Results of the SAKURA Program
Maturi, Raj
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[8] Efficacy and Safety Results From the SAKURA Program: Two Phase III Studies of Intravitreal Sirolimus Every Other Month for Non-infectious Uveitis of the Posterior Segment
Quan Dong Nguyen
Merrill, Pauline
Clark, W. Lloyd
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[9] The SATURN Study (SARIL-NIU): Sarilumab for the Treatment of Posterior Segment Non-Infectious Uveitis (NIU)
Quan Dong Nguyen
Sundaram, Preethi A.
Erickson, Kristine
Varona, Rafael
Drouot, David
Corp-dit-Genti, Valerie
Kazmi, Husain
Vitti, Robert
de Smet, Marc D.
[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[10] Sarilumab for the treatment of posterior segment non-infectious uveitis (NIU): The SATURN (SARIL-NIU) study
Heissigerova, J.
Sundaram, P. A.
Erickson, K.
Varona, R.
Corp-dit-Genti, V.
Vitti, R.
Buggage, R.
Rihova, E.
Nguyen, Q. D.
[J]. ACTA OPHTHALMOLOGICA, 2015, 93

← 1 2 3 4 5 →